Serum Institute
-
{
- All
- News
- Videos
- Photos
-
Serum Institute's Cyrus Poonawalla Buys Raja Ravi Varma Painting For Record Rs 167 Crore
Managing director of the Serum Institute of India, Dr Cyrus S Poonawalla, acquired Raja Ravi Varma's iconic painting Yashoda and Krishna
-
Virat Kohli May Play For New Owners As RCB Heads For Big Change
Earlier this year, RCB lifted its maiden title by trouncing Punjab Kings in the final of the 18th edition of the cash-rich league.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
"My Wife Loves Staring At Me": Adar Poonawalla Mocks L&T Chief's Remark
Serum Institute of India CEO Adar Poonawalla has weighed in on the ongoing debate about work-life balance, advocating for the importance of quality over the quantity of work hours.
-
Serum Institute Says Working To Develop Monkeypox Vaccine
Serum Institute of India on Tuesday said it is currently working to develop a vaccine for Monkeypox, with positive outcomes expected in a year's time.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute's Cyrus Poonawalla Buys Raja Ravi Varma Painting For Record Rs 167 Crore
Managing director of the Serum Institute of India, Dr Cyrus S Poonawalla, acquired Raja Ravi Varma's iconic painting Yashoda and Krishna
-
Virat Kohli May Play For New Owners As RCB Heads For Big Change
Earlier this year, RCB lifted its maiden title by trouncing Punjab Kings in the final of the 18th edition of the cash-rich league.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
"My Wife Loves Staring At Me": Adar Poonawalla Mocks L&T Chief's Remark
Serum Institute of India CEO Adar Poonawalla has weighed in on the ongoing debate about work-life balance, advocating for the importance of quality over the quantity of work hours.
-
Serum Institute Says Working To Develop Monkeypox Vaccine
Serum Institute of India on Tuesday said it is currently working to develop a vaccine for Monkeypox, with positive outcomes expected in a year's time.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
